Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
Titel:
Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
Auteur:
Tolaney, Sara M. Nechushtan, Hovav Ron, Ilan-Gil Schöffski, Patrick Awada, Ahmad Yasenchak, Chris A. Laird, A. Douglas O’Keeffe, Bridget Shapiro, Geoffrey I. Winer, Eric P.